Call for proposals for African scientists: malaria drug development
Call for proposals
Medicines for Malaria
Venture’s 7th African call for proposals 2024
To be eligible for consideration for funding as part of this call, MMV welcomes proposals only from African scientists focused in the following priority areas:
Compounds with confirmed activity on any antimalarial lifecycle stage
Novel molecules with confirmed activity (EC50 < 10uM) and a medicinal chemistry plan that tackles any known or anticipated liability. In line with MMV strategic goals, priority will be given to compounds with potential for optimization as drugs for chemoprevention with a human half-life >120h.
Assay development and screening
Assay development and screening to support discovery or development of novel antimalarials.
Computer-aided drug discovery
Use of computational approaches (cheminformatic and/or bioinformatic) to discover new molecules with predicted antimalarial activity or new antimalarial drug targets.
Please complete the African Letter of Interest template. Proposals involving a biological target should also include the target information template. See further instructions on how to complete the African Letter of Interest.
The proposals funded as part of this call will have a project start date of 1 January 2025.
All applications for any of the above must use the specified templates and should be sent electronically to proposals@mmv.org by Friday, 30 August 2024 at 12:00 pm (CEST).
Instructions
Instructions for submission of African proposals
Contact us
+41 22 555 03 00
info@mmv.org
Apply below
